334 Phase II study evaluating a chemokine-modulatory (CKM) regimen in patients with colorectal cancer (CRC) metastatic to the liver
oleh: Pawel Kalinski, Patrick Boland, Kristopher Attwood, Melissa Grimm, Sarbajit Mukherjee, Medhavi Gupta
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2020-11-01 |
Deskripsi
No description available for this item.